Recode Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Sensible Biotechnologiessensible.bioin𝕏Feb 2023
Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development.
AI & Machine LearningBiotechDeep TechHealthtechOxford, GB
Miroslav Gasparek(Founder)inMarian Kupculak(Founder)in
PartnerArmen A. Vidian· solo GP
Co-investorsCivilization Ventures Management, LlcKAYAY CombinatorZAKA VCBlueYard Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.